as on November 12, 2025 at 2:28 am IST
Day's Low
5.96%
Downside
52 Week's Low
52 Week's High
46.71%
Downside
448.59%
Upside
Check Kure Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$41.5M
EPS (TTM)
-4.52
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-207.36%
Compare market cap, revenue, PE, and other key metrics of Kure Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $41.5M | NA | NA | 0.00% | |
| BUY | $41.3B | 426.19% | -16.34 | -264.83% | |
| BUY | $58.4B | 241.25% | 1424.84 | 1.36% | |
| BUY | $106.9B | 96.61% | 29.68 | 31.35% | |
| BUY | $68.8B | 21.15% | 15.7 | 32.13% |
The Kure Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Kure Therapeutics Inc investment value today
Current value as on today
₹23,547
Returns
Returns from Kure Therapeutics Inc Stock
Dollar Returns*
₹5,097 (+5.1%)
Search interest for Kure Therapeutics Inc Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, OKUR stock has moved up by 58.5%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 915.7% return, outperforming this stock by 1004.3%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 176.1% return, outperforming this stock by 257.8%
| Organisation | Kure Therapeutics Inc |
| Headquarters | 6707 Winchester Circle, Boulder, CO, United States, 80301 |
| CEO | Dr. Nicholas A. Saccomano Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Samuel Agresta M.D., M.P.H. | Chief Medical Officer |
Mr. Rogan P. Nunn J.D. | General Counsel & Secretary |
Dr. James Blake Ph.D. | Senior Vice President of Computational Drug Discovery |
Dr. Mark L. Boys Ph.D. | Senior Vice President of Discovery Chemistry |
Dr. Nicholas A. Saccomano Ph.D. | President, CEO & Director |
Mr. Jason A. Leverone CPA | Chief Financial Officer |
Ms. Roberta Alton | Senior VP of Clinical Operations |
Dr. Dylan Hartley Ph.D. | Chief Scientific Officer |
Dr. Kevin S. Litwiler Ph.D. | Senior Vice President of DMPK & Clinical Pharmacology |
Kure Therapeutics Inc share price today is $3.19 as on at the close of the market. Kure Therapeutics Inc share today touched a day high of $3.19 and a low of $3.
Kure Therapeutics Inc share touched a 52 week high of $17.5 on and a 52 week low of $1.7 on . Kure Therapeutics Inc stock price today i.e. is closed at $3.19,which is 81.77% down from its 52 week high and 87.65% up from its 52 week low.
Kure Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Kure Therapeutics Inc (OKUR) shares with as little as ₹88.618 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.18 in Kure Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kure Therapeutics Inc share’s latest price of $3.19 as on November 12, 2025 at 2:28 am IST, you will get 3.1348 shares of Kure Therapeutics Inc. Learn more about
fractional shares .